BG97446A - Фармацевтични състави на 5-(2-хлор-1-хидроксиетил)- 4-метилтиазол - Google Patents

Фармацевтични състави на 5-(2-хлор-1-хидроксиетил)- 4-метилтиазол

Info

Publication number: BG97446A
Authority: BG; Bulgaria
Prior art keywords: hydroxyethyl; chloro; pharmaceutical compositions; methythiazole; methylthiazole
Prior art date: 1990-08-15

Application number

BG97446A

Other languages

Bulgarian (bg)

English (en)

Inventor

Bernard Boar

Alan Cross

Alfred Green

Curt-Eric Hagberg

Original Assignee

Aktiebolaget Astra

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-15

Filing date

1993-02-15

Publication date

1994-03-24

1993-02-15 Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra

1994-03-24 Publication of BG97446A publication Critical patent/BG97446A/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
-1 2-CHLORO-1-HYDROXYETHYL Chemical class 0.000 title 1
OOKATFCTRGAPQX-UHFFFAOYSA-N 2-chloro-1-(4-methyl-1,3-thiazol-5-yl)ethanol Chemical compound CC=1N=CSC=1C(O)CCl OOKATFCTRGAPQX-UHFFFAOYSA-N 0.000 abstract 1
230000001773 anti-convulsant effect Effects 0.000 abstract 1
230000004770 neurodegeneration Effects 0.000 abstract 1
230000003287 optical effect Effects 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000000932 sedative agent Substances 0.000 abstract 1
230000001624 sedative effect Effects 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)

BG97446A 1990-08-15 1993-02-15 Фармацевтични състави на 5-(2-хлор-1-хидроксиетил)- 4-метилтиазол BG97446A (bg)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9002659A SE9002659D0 (sv)	1990-08-15	1990-08-15	New pharmaceutical formulations
PCT/SE1991/000522 WO1992003134A1 (en)	1990-08-15	1991-08-07	New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole

Publications (1)

Publication Number	Publication Date
BG97446A true BG97446A (bg)	1994-03-24

Family

ID=20380161

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG97446A BG97446A (bg)	1990-08-15	1993-02-15	Фармацевтични състави на 5-(2-хлор-1-хидроксиетил)- 4-метилтиазол

Country Status (26)

Country	Link
US (1)	US5385921A (de)
EP (1)	EP0619734B1 (de)
JP (1)	JP3094077B2 (de)
AT (1)	ATE164066T1 (de)
AU (1)	AU657490B2 (de)
BG (1)	BG97446A (de)
CA (1)	CA2088775A1 (de)
CZ (1)	CZ279586B6 (de)
DE (1)	DE69129126T2 (de)
DK (1)	DK0619734T3 (de)
ES (1)	ES2114891T3 (de)
FI (1)	FI930608L (de)
HU (1)	HUT65821A (de)
IE (1)	IE912818A1 (de)
IL (1)	IL99169A (de)
IS (1)	IS3743A7 (de)
LT (1)	LT3978B (de)
LV (1)	LV10921B (de)
NO (1)	NO303447B1 (de)
NZ (1)	NZ239329A (de)
PT (1)	PT98688B (de)
RO (1)	RO112994B1 (de)
RU (1)	RU2093155C1 (de)
SE (1)	SE9002659D0 (de)
SK (1)	SK8793A3 (de)
WO (1)	WO1992003134A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9901658D0 (sv) *	1999-05-06	1999-05-06	Astra Ab	New formulation
SE9904177D0 (sv) *	1999-11-18	1999-11-18	Astra Ab	Novel compounds
WO2002083863A2 (en)	2001-04-17	2002-10-24	Sepracor, Inc.	Thiazole and other heterocyclic ligands and use thereof
CN103772313B (zh) *	2014-01-02	2015-10-14	郑桂富	一种4-甲基-5-(2-羟乙基)噻唑的合成方法
CN112262814A (zh) *	2020-10-26	2021-01-26	宜宾学院	油樟叶渣发酵床养鸡方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2825966A1 (de) *	1978-06-14	1980-01-03	Basf Ag	Saures galvanisches nickelbad, das sulfobetaine als glanz- und einebnungsmittel enthaelt
GB8600783D0 (en) *	1986-01-14	1986-02-19	Merck Sharp & Dohme	N-methyl-d-aspartate receptor antagonists

1990
- 1990-08-15 SE SE9002659A patent/SE9002659D0/xx unknown
1991
- 1991-08-07 EP EP91915138A patent/EP0619734B1/de not_active Expired - Lifetime
- 1991-08-07 ES ES91915138T patent/ES2114891T3/es not_active Expired - Lifetime
- 1991-08-07 AU AU84092/91A patent/AU657490B2/en not_active Ceased
- 1991-08-07 RU RU9193004984A patent/RU2093155C1/ru active
- 1991-08-07 FI FI930608A patent/FI930608L/fi unknown
- 1991-08-07 HU HU9300388A patent/HUT65821A/hu unknown
- 1991-08-07 RO RO93-00194A patent/RO112994B1/ro unknown
- 1991-08-07 DE DE69129126T patent/DE69129126T2/de not_active Expired - Lifetime
- 1991-08-07 WO PCT/SE1991/000522 patent/WO1992003134A1/en not_active Ceased
- 1991-08-07 CZ CS93166A patent/CZ279586B6/cs unknown
- 1991-08-07 SK SK8793A patent/SK8793A3/sk unknown
- 1991-08-07 AT AT91915138T patent/ATE164066T1/de not_active IP Right Cessation
- 1991-08-07 DK DK91915138T patent/DK0619734T3/da active
- 1991-08-07 JP JP03514007A patent/JP3094077B2/ja not_active Expired - Lifetime
- 1991-08-07 CA CA002088775A patent/CA2088775A1/en not_active Withdrawn
- 1991-08-09 NZ NZ239329A patent/NZ239329A/en unknown
- 1991-08-09 IE IE281891A patent/IE912818A1/en unknown
- 1991-08-12 IL IL9916991A patent/IL99169A/en active IP Right Grant
- 1991-08-14 PT PT98688A patent/PT98688B/pt not_active IP Right Cessation
- 1991-08-14 IS IS3743A patent/IS3743A7/is unknown
- 1991-08-14 US US07/744,914 patent/US5385921A/en not_active Expired - Lifetime
1993
- 1993-02-09 NO NO930452A patent/NO303447B1/no not_active IP Right Cessation
- 1993-02-15 BG BG97446A patent/BG97446A/xx unknown
- 1993-08-10 LV LVP-93-1024A patent/LV10921B/en unknown
- 1993-12-30 LT LTIP1714A patent/LT3978B/lt not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0619734A1 (de)	1994-10-19
PT98688A (pt)	1992-07-31
NO930452L (no)	1993-02-09
NO303447B1 (no)	1998-07-13
JP3094077B2 (ja)	2000-10-03
FI930608A7 (fi)	1993-02-11
IL99169A0 (en)	1992-07-15
IL99169A (en)	1995-10-31
CZ279586B6 (cs)	1995-05-17
RO112994B1 (ro)	1998-03-30
EP0619734B1 (de)	1998-03-18
AU8409291A (en)	1992-03-17
SK8793A3 (en)	1993-07-07
PT98688B (pt)	1999-01-29
NO930452D0 (no)	1993-02-09
LT3978B (en)	1996-06-25
IS3743A7 (is)	1992-02-16
LTIP1714A (en)	1995-09-25
DE69129126D1 (de)	1998-04-23
AU657490B2 (en)	1995-03-16
IE912818A1 (en)	1992-02-26
CA2088775A1 (en)	1992-02-16
CZ16693A3 (en)	1994-02-16
RU2093155C1 (ru)	1997-10-20
HUT65821A (en)	1994-07-28
NZ239329A (en)	1994-11-25
DE69129126T2 (de)	1998-07-23
DK0619734T3 (da)	1998-10-05
FI930608A0 (fi)	1993-02-11
US5385921A (en)	1995-01-31
LV10921B (en)	1996-08-20
SE9002659D0 (sv)	1990-08-15
ATE164066T1 (de)	1998-04-15
JPH06500097A (ja)	1994-01-06
ES2114891T3 (es)	1998-06-16
FI930608L (fi)	1993-02-11
HU9300388D0 (en)	1993-04-28
WO1992003134A1 (en)	1992-03-05
LV10921A (lv)	1995-12-20

Publication	Publication Date	Title
FI963424A0 (fi)	1996-09-02	Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
NO884467D0 (no)	1988-10-07	Analogifremgangsmaate for fremstilling av aminomethyloxooxazolidinyl-ycloalkylbenzenderivater.
NO890443D0 (no)	1989-02-03	Fremgangsmaate for fremstilling av alkenylsubstituerte benzenderivater.
NO904595L (no)	1991-08-06	Fremgangsmaate for potensiering av den analgetiske effekt av curcuminoider.
FI895064A7 (fi)	1990-04-27	Syklosporiinia sisältäviä koostumuksia silmätulehdusten hoitoon
NO904986L (no)	1991-05-21	Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
FI930723A0 (fi)	1993-02-18	Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi
NO903941D0 (no)	1990-09-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
MA22495A1 (fr)	1992-12-31	Derives d'amidinophenylalanine, procede pour leur preparation et leur utilisation
KR920700625A (ko)	1992-08-10	고혈압 치료를 위한 신장에 선택적인 프로드러그(Prodrug)
ITMI910456A0 (it)	1991-02-21	Composizione farmaceutica per il trattamento della cataratta
TR27833A (tr)	1995-08-31	Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
IT1270905B (it)	1997-05-13	Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
NO913117D0 (no)	1991-08-09	Fremgangsmaate for behandling av benoedeleggende sykdommer.
LV10921A (lv)	1995-12-20	Jaunas farmaceitiskas kompozicijas
RU93004984A (ru)	1995-05-10	Фармацевтическая композиция на основе 5(2-хлор-1-гидроксиэтил)-4-метилтиазола, применение 5-(2-хлор-1-гидроксиэтил)-4-метил-тиазола для лечения, способ лечения, соли 5-(2-хлор-1-гидроксиэтил)-4-метилтиазола
FR2696926B1 (fr)	1994-12-09	Prothèse totale du genou du type intracondylienne.
NO905003D0 (no)	1990-11-19	Fremgangsmaate for fremstilling av proteaseinhibitorer frapotetsaft.
FI912968A0 (fi)	1991-06-18	Farmaceutiska kombinationspreparat som innehaoller kefalosporin- och xantinderivat och anvaendning av dessa.
FI932650A7 (fi)	1993-06-10	B-solujen maligniteettien hoitoon tarkoitetut farmaseuttiset seokset
NO890287L (no)	1989-08-04	Fremstilling av beta-laktam-antibiotika.
LV5046A3 (lv)	1993-06-10	3-(2,2,2-trimetilhidrazinij)propionata dihidrata iegusanas panemiens
UA26433A (uk)	1999-08-30	Спосіб отримаhhя аміhотіазолільhих похідhих цефалоспориhу та їх солей
MX9202442A (es)	1992-11-01	Derivados de azol.
ITMI911930A1 (it)	1993-01-12	Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico.